Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension

Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension

Aim. To study candesartan effectiveness and tolerability in essential arterial hypertension (ГАН) and AH associated with chronic renal disease.Material and methods. This 12-week open, controlled study included 14 patients (mean age 43,4±16 years) with diagnosed ГАН (n=9) or secondary AH of renal eti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika 2008-12, Vol.7 (7), p.34-38
Hauptverfasser: N. M. Chikhladze, O. A. Sivakova, E. V. Blinova, T. A. Sakhnova, I. P. Kolos, G. N. Litonova, I. E. Chazova
Format: Artikel
Sprache:rus
Schlagworte:
arterial hypertension
candesartan
microalbuminuria
organo-protection
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim. To study candesartan effectiveness and tolerability in essential arterial hypertension (ГАН) and AH associated with chronic renal disease.Material and methods. This 12-week open, controlled study included 14 patients (mean age 43,4±16 years) with diagnosed ГАН (n=9) or secondary AH of renal etiology (n=5). At baseline and after 12 weeks of candesartan therapy, office blood pressure (BP) measurement, 24-hour BP monitoring (BPM), vectorcardiography and decar-tography measurements of plasma renin activity, aldosterone, potassium levels and microalbuminuria (MAU) were performed.Results. Target BP level
ISSN:1728-8800
2619-0125